The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
Abstract
To prevent hemophilic arthropathy, prophylactic treatment of children with severe hemophilia should be started before joint damage has occurred. However, treatment is expensive, and the burden of regular venipunctures in young children is high. With the aim of providing information on starting prophylaxis on the basis of individual patient characteristics, the effect of postponing prophylaxis on long-term arthropathy was studied in a cohort of 76 patients with severe hemophilia born between 1965 and 1985. The median age at first joint bleed was 2.2 years (range, 0.2-5.8). Prophylaxis was started at a median age of 6 years (interquartile range [IQR], 4-9), and the median annual clotting factor use on prophylaxis was 1750 IU/kg/y (31 IU/kg/wk). Hemophilic arthropathy was measured by the Pettersson score (maximum, 78 points). At a median age of 19 years, the median Pettersson score was 7 points (IQR, 0-17). After 2 decades of follow-up, the Pettersson score was 8% higher (95% confidence interval, 1%-16%) for every year prophylaxis was postponed after the first joint bleed. This effect was independent of age at Pettersson score, age at first joint bleed, and prophylactic dose used. In conclusion, most patients have their first joint bleed after the age of 2 years. Patients who start prophylaxis soon after the first joint bleed show little arthropathy in adulthood. The longer the start of prophylaxis is postponed after the first joint bleed, the higher the risk of developing arthropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B
NILSSON, I. M., BERNTORP, E., LÖFQVIST, T., & PETTERSSON, H. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00546.x · Cited by 961
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
ALEDORT, L. M., HASCHMEYER, R. H., PETTERSSON, H., & THE ORTHOPAEDIC OUTCOME STUDY GROUP (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00815.x · Cited by 611
Haemophilia prophylaxis in young patients–a long‐term follow‐up
LÖFQVIST, T., NILSSON, I. M., BERNTORP, E., & PETTERSSON, H. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.130135000.x · Cited by 332
Modern treatment of haemophilia.
Berntorp, E. E., Boulyjenkov, V., Brettler, D. B., Chandy, M., Jones, P., Lee, C. A., Lusher, J., Mannucci, P. M., Peak, I., & RICKARD, K. A. (1995) · Europe PMC (PubMed Central) · Cited by 191
HAEMOPHILIA PROPHYLAXIS IN SWEDEN
Nilsson, I. M., Hedner, U. K. E., & Ahlberg, A. (1976) · Acta Paediatrica · doi:10.1111/j.1651-2227.1976.tb16525.x · Cited by 160
Lee, C. A., Kessler, C. M., Varon, D., Martinowitz, U. P., Heim, M., Kreuz, W., Escuriola‐Ettingshausen, C., Funk, M. J., SCHMIDT, H., & Kornhuber, B. (1998) · Haemophilia · doi:10.1046/j.1365-2516.1998.440413.x · Cited by 154
Results of secondary prophylaxis in children with severe hemophilia
Manco‐Johnson, M. J., Nuss, R., Geraghty, S. J., Funk, S. M., & Kilcoyne, R. F. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470209 · Cited by 146
Prophylaxis with Factor Concentrates in Preventing Hemophilic Arthropathy
Petrini, P., Lindvall, N., Egberg, N., & Blombäck, M. (1991) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199123000-00006 · Cited by 136
Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis
Smith, P. S., Teutsch, S. M., Shaffer, P. A., Rolka, H. R., & Evatt, B. L. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70076-8 · Cited by 127
Cited by
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
GRINGERI, A., LUNDIN, B., VON MACKENSEN, S., MANTOVANI, L., & MANNUCCI, P. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04214.x · Cited by 454
Gouw, S. C., van den Berg, H. M., Fischer, K., Auerswald, G., Carcao, M., Chalmers, E., Chambost, H., Kurnik, K., Liesner, R., Petrini, P., et al. (2013) · Blood · doi:10.1182/blood-2012-09-457036 · Cited by 332
Self-citationManco-Johnson, M. J., Soucie, J. M., & Gill, J. C. (2017) · Blood · doi:10.1182/blood-2016-02-683169 · Cited by 166
Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study
Schrijvers, L. H., Beijlevelt ‐ van der Zande, M., Peters, M., Lock, J., Cnossen, M. H., Schuurmans, M. J., & Fischer, K. (2016) · British Journal of Haematology · doi:10.1111/bjh.14072 · Cited by 64
Self-citation
Metadata
- Authors
- Fischer, K., van der Bom, J. G., Mauser-Bunschoten, E. P., Roosendaal, G., Prejs, R., de Kleijn, P., Grobbee, D. E., & van den Berg, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-04-01
- Volume
- 99
- Issue
- 7
- Pages
- 2337-2341
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1979670895
- Cited by
- 258
- References
- 15
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. https://app.cochat.ai/papers/10.1182/blood.v99.7.2337
- The paper
- Fischer, K., van der Bom, J. G., Mauser-Bunschoten, E. P., Roosendaal, G., Prejs, R., de Kleijn, P., Grobbee, D. E., & van den Berg, M. (2002). The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood. https://doi.org/10.1182/blood.v99.7.2337
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.